Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for opportunistic salpingectomy for ovarian cancer prevention; and requiring the Maryland Health Care Commission to conduct a mandated benefits study of coverage of salpingectomy that is not opportunistic for individuals who are not at high risk of ovarian cancer and report the findings of the study to the Senate Finance Committee and the House Health Committee by December 1, 2026.